未登录

J

Jie Sun

capital medical university

H指数:9

被引数:262

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Barriers to dental care and parental attitudes toward oral health in children with haemophilia: a cross-sectional study in China

中国儿童血友病患者口腔护理障碍及家长对口腔健康的态度：一项横断面研究

European Archives of Paediatric Dentistry

IF2

2026-01-010

PRE

Causal association between modifiable risk factors and aortic aneurysm and aortic dissection: A comprehensive Mendelian randomization study

可改变风险因素与主动脉瘤及主动脉夹层之间的因果关联：一项全面的孟德尔随机化研究

IF1.4

2025-12-050

PRE

Nanoparticle-Hydrogel Sustained-Release System for the Delivery of si-NEDD4: A Promising Strategy for the Treatment of Keloids

ACS BIOMATERIALS SCIENCE & ENGINEERING

IF5.5

2025-12-010

PRE

Fructose intake driven glycolysis-ROS-EGFR axis specifically promotes the generation and pathogenicity of Th17 cells

果糖摄入驱动的糖酵解-ROS-EGFR轴特异性地促进Th17细胞的生成和致病性。

Nature Communications

IF15.7

2025-11-230

OAAI

METTL3 governs thymocyte development and thymic involution by regulating ferroptosis

Mettl3通过调控铁死亡来调控胸腺细胞发育和胸腺萎缩

IF19.4

2024-10-231

PRE

Length Early immune tolerance induction is a unique predictor of favorable outcomes in hemophilia A children with intron 22 inversion and high-responding inhibitors

THROMBOSIS RESEARCH

IF3.4

2023-06-010

PRE

Low-dose immune tolerance induction therapy in severe hemophilia a children in China: Starting earlier resulted in better inhibitor eradication outcomes

THROMBOSIS RESEARCH

IF3.4

2023-05-013

OAAI

The efficacy of sequential MMF-rescue-regimen to eradicate inhibitors for refractory severe hemophilia A inhibitor children in China

THROMBOSIS RESEARCH

IF3.4

2023-04-010

PRE

The efficacy of the rituximab-containing rescue-regimen for severe hemophilia A inhibitor children who relapsed following successful immune tolerance induction with rituximab in China

含利妥昔单抗的救护方案对中国利妥昔单抗成功诱导免疫耐受后复发的严重血友病A抑制剂儿童的疗效

THROMBOSIS RESEARCH

IF3.4

2023-03-010

PRE

Low-dose immune tolerance induction in children with severe hemophilia A with high-titer inhibitors: Type of factor 8 mutation and outcomes

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS

IF3.4

2022-10-011

OAAI

Morphometric Integrated Classification Index: A Multisite Model-Based, Interpretable, Shareable and Evolvable Biomarker for Schizophrenia

SCHIZOPHRENIA BULLETIN

IF4.8

2022-08-045

OA

Eradication of FIX inhibitor in haemophilia B children using low-dose immune tolerance induction with rituximab-based immunosuppressive agent(s) in China

IF3

2022-05-033

PRE

F8 gene mutation spectrum in severe hemophilia A with inhibitors: A large cohort data analysis from a single center in China

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS

IF3.4

2022-04-014

OAAI

N6-methyladenosine methyltransferase WTAP-stabilized FOXD2-AS1 promotes the osteosarcoma progression through m6A/FOXM1 axis

IF4.2

2022-03-3118

OAAI

CHIR-99021 regulates mitochondrial remodelling via β-catenin signalling and miRNA expression during endodermal differentiation

JOURNAL OF CELL SCIENCE

IF3.6

2019-07-3122

OAAI